Stocks
Gilead Sciences, Inc.GILD
NASDAQHealthcareBiotechnology$144.99-0.15%
A U.S. biopharmaceutical company focused on antiviral therapies and specialty medicines, with leading franchises in HIV treatment and prevention. Its portfolio also includes therapies for hepatitis, oncology, and cell therapy developed through internal research and acquisitions. Investors closely wa...
Market Cap: $180.0B52W Range: $93.37 – $157.29
This page tracks all publicly disclosed congressional trades in Gilead Sciences, Inc. (GILD), a company in the Healthcare sector. 15 members of Congress have disclosed trades in this stock, including 26 purchases and 24 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
50
Unique Politicians
15
Buys
26
Sells
24
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-01-29 | Rohit Khanna | buy | $1K – $15K |
| 2026-01-27 | Josh Gottheimer | buy | $1K – $15K |